Department of Defense Archive — Page 2 of 3
-
June 29, 2017
Genetics of lung cancer survival
Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans. -
May 17, 2017
Blood type link to cancer survival
Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study. -
October 6, 2016
Studies aim to speed, track peripheral nerve recovery
Surgeons have limited tools to successfully repair and track the recovery of peripheral nerves that have been severely damaged as a result of a traumatic injury, but Vanderbilt investigators hope to change this through research studies recently funded with more than $3 million in grants from the Department of Defense and the National Institutes of Health. -
August 26, 2016
New breast cancer driver
Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers. -
July 20, 2016
Breast cancer: finding the smoking gun
A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes. -
August 11, 2015
Drug combos enhance ovarian cancer cell death
Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. -
May 6, 2015
Neurofibromin fine-tunes bone growth
The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered.